Evidence map›Paper›PMID 25118635›Full record

ArticleInternational journal of oncology2014

A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population.

Yusaku Watanabe, Kiyoshi Yoshimura, Koichi Yoshikawa, Ryoichi Tsunedomi, Yoshitaro Shindo, Sou Matsukuma, Noriko Maeda, Shinsuke Kanekiyo, Nobuaki Suzuki, Atsuo Kuramasu and 6 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Yusaku WatanabeDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Kiyoshi YoshimuraDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Koichi YoshikawaDepartment of Neurosurgery, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Ryoichi TsunedomiDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Yoshitaro ShindoDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Sou MatsukumaDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Noriko MaedaDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Shinsuke KanekiyoDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Nobuaki SuzukiDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Atsuo KuramasuDepartment of Molecular Pharmacology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Kouhei SonodaDepartment of Ophthalmology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Koji TamadaDepartment of Immunology and Cell Signaling Analysis, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Sei KobayashiDepartment of Molecular Physiology and Medical Bioregulation, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Hideyuki SayaDivision of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582, Japan.
Shoichi HazamaDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Masaaki OkaDepartment of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Yamaguchi University · JPKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) have been studied for their self-renewal capacity and pluripotency, as well as their resistance to anticancer therapy and their ability to metastasize to distant organs. CSCs are difficult to study because their population is quite low in tumor specimens. To overcome this problem, we established a culture method to induce a pancreatic cancer stem-like cell (P-CSLC)-enriched population from human pancreatic cancer cell lines. Human pancreatic cancer cell lines established at our department were cultured in CSC-inducing media containing epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), leukemia inhibitory factor (LIF), neural cell survivor factor-1 (NSF-1), and N-acetylcysteine. Sphere cells were obtained and then transferred to a laminin-coated dish and cultured for approximately two months. The surface markers, gene expression, aldehyde dehydrogenase (ALDH) activity, cell cycle, and tumorigenicity of these induced cells were examined for their stem cell-like characteristics. The population of these induced cells expanded within a few months. The ratio of CD24high, CD44high, epithelial specific antigen (ESA) high, and CD44variant (CD44v) high cells in the induced cells was greatly enriched. The induced cells stayed in the G0/G1 phase and demonstrated mesenchymal and stemness properties. The induced cells had high tumorigenic potential. Thus, we established a culture method to induce a P-CSLC-enriched population from human pancreatic cancer cell lines. The CSLC population was enriched approximately 100-fold with this method. Our culture method may contribute to the precise analysis of CSCs and thus support the establishment of CSC-targeting therapy.

Indexed as

Cell Line, TumorCulture MediaEpithelial-Mesenchymal TransitionFlow CytometryHumansIntercellular Signaling Peptides and ProteinsNeoplastic Stem CellsNeural Stem CellsPancreatic NeoplasmsCulture MediaIntercellular Signaling Peptides and Proteins

Identifiers

PMID25118635
PMCPMC4203336
OpenAlexW2034982916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.